JJohnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.
Work here?Claim your company
Industries
Company Size
10,001+
Company Stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
The average 1-year certificate of deposit (CD) paid 1.76% on October 1, 2026, according to the Federal Deposit Insurance Corporation (FDIC). That is well below the Federal Reserve's target range, whose upper bound was 4.00% as of November 6. Some savers are weighing blue-chip dividend stocks instead. Realty Income yields 5.21% and Verizon 6.22%, while Procter & Gamble yields 2.65%, Coca-Cola 2.13%, and Johnson & Johnson 1.91%. Microsoft yields 0.67%. A CD rate is locked for the term, but a dividend can grow or be cut. Qualified dividends are taxed at 0%, 15%, or 20%, while CD interest is taxed as ordinary income.
Johnson & Johnson said the US Food and Drug Administration (FDA) granted accelerated approval to RYBREVANT FASPRO, a subcutaneous injection, for adults with recurrent or metastatic head and neck squamous cell carcinoma. The drug is for patients whose disease has progressed on or after platinum-based chemotherapy and an anti-PD-(L)1 antibody. It excludes HPV-associated oropharyngeal cancer. It is the first dual-targeted therapy in this setting, hitting both the EGFR and MET pathways. It is also the drug's first approval beyond non-small cell lung cancer. In a 102-patient Phase 1b/2 trial, the confirmed overall response rate was 42%. Of responders, 56% maintained a response for more than six months. Continued approval may depend on results from the ongoing Phase 3 OrigAMI-5 trial.
Four Dividend Kings, companies that have raised payouts for at least 50 years in a row, stand out for retirees who want growing income, according to a review of dividend safety and cash flow. The four are Emerson Electric, Cincinnati Financial, Johnson & Johnson, and Coca-Cola. Emerson has the longest streak, entering its 71st year after a 7% raise to $0.595 a quarter. The dividend uses about 34% of expected free cash flow, though the stock is the most sensitive to the economy. Cincinnati Financial pays out just 22% of earnings. Johnson & Johnson raised its quarterly dividend 3.1% to $1.34, its 64th straight year of increases. Coca-Cola offers the highest yield, about 2.20%, backed by net debt of 1.3 times EBITDA.
Splitting $250,000 equally across Procter & Gamble, Coca-Cola, and Johnson & Johnson would yield about $5,581 a year in dividends, a blended yield of 2.23%. Each stake would be $83,333.33. All three are Dividend Kings. P&G has raised its payout for 70 straight years, Johnson & Johnson for 64, and Coca-Cola for 63. P&G would pay $2,153.57 a year at a 2.58% forward yield. Coca-Cola would add $1,823.56 at 2.19%, and Johnson & Johnson $1,603.83 at 1.92%. Johnson & Johnson's yield is lowest because its shares have gained 36.74% this year. Coca-Cola's have risen 41.28%, and P&G's 20.95%. Risks include biosimilar competition for Johnson & Johnson's STELARA, Coca-Cola's IRS tax litigation, and P&G's commodity costs of about $1.4 billion after tax.
Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
10,001+
Company Stage
IPO
Headquarters
New Brunswick, NJ
Founded
1886
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs